Emergingby GlyphEU approves KOSTAIVE, the first self-amplifying mRNA COVID-19 vaccine
CSL and Arcturus vaccine uses LUNAR lipid-mediated delivery.
Nanotechnologynewsroom.csl.com
Arcturus Therapeutics
Public companyUS1 field
Where it works
| Technology | ||
|---|---|---|
| NanotechnologyCommercial mRNA company with LUNAR lipid-mediated delivery and self-amplifying mRNA. | Commercial mRNA company with LUNAR lipid-mediated delivery and self-amplifying mRNA. | newsroom.csl.com |
Events
About
- Source
- newsroom.csl.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
Arcturus Therapeutics
Joined in Nanotechnology. Commercial mRNA company with LUNAR lipid-mediated delivery and self-amplifying mRNA.
Arcturus Therapeutics
Added in Nanotechnology. Commercial mRNA company with LUNAR lipid-mediated delivery and self-amplifying mRNA.